Scientists crack secret to longevity
Scientists seem to have cracked the secret of
longevity of supercentenarians -those over the age of 110 years. New
studies have found that these really old people possess an excess of
cytotoxic CD4 T, a type of immune cells.
Scientists used single-cell RNA (Ribonucleic acid) analysis to make the discovery.
Supercentenarians are somewhat of a unique group of people. First, they are extremely rare. For example, in Japan in 2015 there were more than 61,000 people over the age of 100, but just 146 over the age of 110.
And studies have found that these individuals were relatively immune to illnesses such as infections and cancer during their whole lifetimes. This led to the idea that it might be that they have a particularly strong immune system, and the researchers are set out to find out what might explain this.
The results of the study were published in the journal 'Proceedings of the National Academy of Sciences (PNAS).'
To answer the question, they looked at circulating immune cells from a group of supercentenarians and younger controls. They acquired a total of 41,208 cells from seven supercentenarians (an average of 5,887 per subject) and 19,994 cells for controls (an average of 3,999 per subject) from five controls aged in their fifties to eighties.
They found that while the number of B-cells was lower in the supercentenarians, the number of T-cells was approximately the same, and in particular, the number of one subset of T-cells was increased in the supercentenarians.
Analysing these cells, the authors found that the supercentenarians had a very high level of cells that are cytotoxic, meaning that they can kill other cells, sometimes amounting to 80 per cent of all T-cells, compared to just 10 or 20 per cent in the controls.
Normally, T-cells with markers known as CD8 are cytotoxic, and those with the CD4 marker are not, so the authors first thought that perhaps CD8-positive cells were increased. But that turned out to not be the case. Rather, it seems that the CD4-positive cells of the supercentenarians had acquired cytotoxic status.
Intriguingly, when the researchers looked at the blood of young donors, there were relatively few CD4-positive cytotoxic cells, indicating that this was not a marker of youth but rather a special characteristic of the supercentenarians.
To look at how these special cells were produced, the team examined the blood cells of two supercentenarians in detail and found that they had arisen from a process of clonal expansion, meaning that many of the cells were the progeny of a single ancestor cell.
According to Kosuke Hashimoto of IMS, the first author of the paper, "We were especially interested in studying this group of people, because we consider them to be a good model of healthy ageing, and this is important in societies like Japan where ageing is proceeding rapidly."
IMS Deputy Director Piero Carninci, one of the leaders of the groups, says, "This research shows how single-cell transcription analysis can help us to understand how individuals are more or less susceptible to diseases.
Scientists used single-cell RNA (Ribonucleic acid) analysis to make the discovery.
Supercentenarians are somewhat of a unique group of people. First, they are extremely rare. For example, in Japan in 2015 there were more than 61,000 people over the age of 100, but just 146 over the age of 110.
And studies have found that these individuals were relatively immune to illnesses such as infections and cancer during their whole lifetimes. This led to the idea that it might be that they have a particularly strong immune system, and the researchers are set out to find out what might explain this.
The results of the study were published in the journal 'Proceedings of the National Academy of Sciences (PNAS).'
To answer the question, they looked at circulating immune cells from a group of supercentenarians and younger controls. They acquired a total of 41,208 cells from seven supercentenarians (an average of 5,887 per subject) and 19,994 cells for controls (an average of 3,999 per subject) from five controls aged in their fifties to eighties.
They found that while the number of B-cells was lower in the supercentenarians, the number of T-cells was approximately the same, and in particular, the number of one subset of T-cells was increased in the supercentenarians.
Analysing these cells, the authors found that the supercentenarians had a very high level of cells that are cytotoxic, meaning that they can kill other cells, sometimes amounting to 80 per cent of all T-cells, compared to just 10 or 20 per cent in the controls.
Normally, T-cells with markers known as CD8 are cytotoxic, and those with the CD4 marker are not, so the authors first thought that perhaps CD8-positive cells were increased. But that turned out to not be the case. Rather, it seems that the CD4-positive cells of the supercentenarians had acquired cytotoxic status.
Intriguingly, when the researchers looked at the blood of young donors, there were relatively few CD4-positive cytotoxic cells, indicating that this was not a marker of youth but rather a special characteristic of the supercentenarians.
To look at how these special cells were produced, the team examined the blood cells of two supercentenarians in detail and found that they had arisen from a process of clonal expansion, meaning that many of the cells were the progeny of a single ancestor cell.
According to Kosuke Hashimoto of IMS, the first author of the paper, "We were especially interested in studying this group of people, because we consider them to be a good model of healthy ageing, and this is important in societies like Japan where ageing is proceeding rapidly."
IMS Deputy Director Piero Carninci, one of the leaders of the groups, says, "This research shows how single-cell transcription analysis can help us to understand how individuals are more or less susceptible to diseases.